Jakafi 5 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6XQV
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $48,587
Award facts
- Contract value 100% obligated
- $48,587.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $48.6K on August 14, 2025, for the supply of Jakafi 5 mg tablets (60-count units) to support federal medical supply needs. This firm fixed-price delivery order, with an ultimate completion date of August 15, 2025, represents execution under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $500M vehicle valid through November 2026. The award carries no set-aside designation, and the place of performance is Park Ridge, Illinois.
The contract delivery supports the Medical Supply Chain operations within the Department of Defense, reflecting DMS Pharmaceutical Group's established role as a critical supplier of branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities. Jakafi (ruxolitinib) is a prescription medication used in the treatment of myelofibrosis and other hematologic disorders, underscoring the vendor's continued provision of specialized pharmaceutical products to Defense Logistics Agency healthcare systems. This delivery order exemplifies the company's consistent performance on federal pharmaceutical procurement, leveraging its woman-owned small business status to compete effectively in government markets.
Quick answers
Who was awarded contract SPE2DX25F6XQV?
SPE2DX25F6XQV was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 14, 2025.
How much is contract SPE2DX25F6XQV worth?
The government has obligated $48,587 on SPE2DX25F6XQV.
Is contract SPE2DX25F6XQV an order under another contract?
Yes. SPE2DX25F6XQV is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XQV competed?
The extent of competition for SPE2DX25F6XQV was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award